ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Brooklyn ImmunoTherapeutics Inc

Brooklyn ImmunoTherapeutics Inc (BTX)

9.79
0.00
(0.00%)
Closed April 26 3:00PM
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0051k17k47k47k2.06M1,000
Operating Income -5.32M-4.6M-5.51M-5.77M-5.79M-4.93M-2.26M-1.12M
Pre Tax Income -5.41M-4.5M-5.6M-6.16M-6.64M-5.53M-26.59M-5.75M
Net Income -5.42M-4.52M-5.59M-6.16M-6.65M-5.54M-26.6M-5.77M
Preferred Dividends 0-8k0-8k0-8k0-8k
Basic Earnings Per Share (EPS) 00000000
EBIT -5.37M-4.83M-5.51M-5.82M-5.79M-4.93M-2.26M-1.05M
EBITDA -5.3M-4.58M-5.49M-5.74M-5.75M-4.89M-2.22M-1.1M
Year End December 30 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 21.27M23.34M19.81M5.8M0068k582k
Operating Income -1.4M203k-1.76M-6.31M-113.73M-27.23M-21.14M-15.67M
Pre Tax Income -1.01M-323k-2.02M-4.42M-122.3M-24.53M-21.67M-44.51M
Net Income -1.08M-275k-2.06M-4.43M-122.32M-24.6M-21.68M-44.56M
Preferred Dividends 0-16k-16k-16k-16k-16k-16k-16k
Basic Earnings Per Share (EPS) -0.402-0.091-0.677-1.419-2.344-4.655-3.896-0.865
EBIT -513k66k-1.77M-4.28M-122.3M-28.4M-21.47M-15.6M
EBITDA 915k3.25M1.67M-3.46M-113.73M-27.07M-21.05M-15.54M